ArticlePLoS medicine2025

Comparative safety and effectiveness of apixaban and rivaroxaban for treatment of cancer-associated venous thromboembolism: A retrospective cohort study.

Jingjing Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.